Unlike other types of cancer, doctors use phases rather than stages to describe the progression of chronic myeloid leukemia (CML). The phases of CML include the chronic phase, accelerated phase, and ...

Chronic myeloid leukemia (CML) blast crisis phase is the last stage of the condition where there are large clusters of immature white blood cells, or blasts, in the bone marrow, organs, and tissue.

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...

This publication is sponsored by Takeda Pharmaceuticals U.S.A., Inc. This clinical brief provides key information on third-generation tyrosine kinase inhibitor for patients with chronic phase chronic ...

—These investigators took a long look at prognosis and survival in patients with CML-BP in the context of TKI treatment. Patients with chronic myeloid leukemia in the blast phase (CML-BP) pose a ...

It is important to distinguish de novo CML-BP from Ph-positive ALL before allogeneic hematopoietic cell transplantation. The effect of BCR::ABL1 mutation status on outcomes of hematopoietic cell ...

A retrospective study found that adolescents and young adults (AYA) receiving tyrosine kinase inhibitors (TKI) therapy for chronic-phase chronic myeloid leukemia (CML) had similar prognoses to older ...